This Coverage Policy Analysis is intended to provide a summary for payers of recent evidence and coverage policy development related to repetitive transcranial magnetic stimulation (rTMS) for the treatment of patients with treatment-resistant depression. The origin of this material arises from the efforts of the New England Comparative Effectiveness Public Advisory Council (CEPAC). CEPAC is an initiative funded by the Agency for Healthcare Research and Quality (AHRQ) and led by our research team at the Institute for Clinical and Economic Review (ICER) at the Massachusetts General Hospital. CEPAC is an independent deliberative body composed of clinician and public representatives whose goal is to aid patients, physicians and policymakers in ...
Repetitive Transcranial Magnetic Stimulation (rTMS) is a safe, painless, effective and natural evid...
OBJECTIVE: Repetitive transcranial magnetic stimulation (rTMS) is proposed for the treatment of dru...
Objective: The aim of this paper is to present the service data results from a clinical repetitive T...
About 30 to 46% of patients with major depressive disorder (MDD) fail to fully respond to initial an...
BackgroundThe clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) in treatment ...
Objective:The aim of this paper is to present the service data results from a clinical repetitive Tr...
Major depressive disorder (MDD) is one of the most common psychiatric disorders, however, current tr...
BACKGROUND: Major depressive disorder (MDD) is one of the most common psychiatric disorders, however...
BACKGROUND: Major depressive disorder (MDD) is one of the most common psychiatric disorders, however...
BackgroundWe conducted an open trial to evaluate the efficacy of repetitive transcranial magnetic st...
In a priority communication in this issue, George et al (2000) present a carefully conducted small-s...
Objective: There is considerable research evidence for the effectiveness of repetitive transcranial ...
Background: Repetitive transcranial magnetic stimulation (rTMS) therapy is a clinically safe, noninv...
Background:Transcranial magnetic stimulation(TMS)is a treatment for majordepressive disorder that is...
Background: We conducted an open trial to evaluate the efficacy of repetitive transcranial magnetic ...
Repetitive Transcranial Magnetic Stimulation (rTMS) is a safe, painless, effective and natural evid...
OBJECTIVE: Repetitive transcranial magnetic stimulation (rTMS) is proposed for the treatment of dru...
Objective: The aim of this paper is to present the service data results from a clinical repetitive T...
About 30 to 46% of patients with major depressive disorder (MDD) fail to fully respond to initial an...
BackgroundThe clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) in treatment ...
Objective:The aim of this paper is to present the service data results from a clinical repetitive Tr...
Major depressive disorder (MDD) is one of the most common psychiatric disorders, however, current tr...
BACKGROUND: Major depressive disorder (MDD) is one of the most common psychiatric disorders, however...
BACKGROUND: Major depressive disorder (MDD) is one of the most common psychiatric disorders, however...
BackgroundWe conducted an open trial to evaluate the efficacy of repetitive transcranial magnetic st...
In a priority communication in this issue, George et al (2000) present a carefully conducted small-s...
Objective: There is considerable research evidence for the effectiveness of repetitive transcranial ...
Background: Repetitive transcranial magnetic stimulation (rTMS) therapy is a clinically safe, noninv...
Background:Transcranial magnetic stimulation(TMS)is a treatment for majordepressive disorder that is...
Background: We conducted an open trial to evaluate the efficacy of repetitive transcranial magnetic ...
Repetitive Transcranial Magnetic Stimulation (rTMS) is a safe, painless, effective and natural evid...
OBJECTIVE: Repetitive transcranial magnetic stimulation (rTMS) is proposed for the treatment of dru...
Objective: The aim of this paper is to present the service data results from a clinical repetitive T...